Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGU

The impact of concomitant use of androgen deprivation therapies (ADT) on the efficacy of piflufolastat F 18-PET/CT in patients with prostate cancer: a sub-group analysis of OSPREY Cohort B

Lawrence Saperstein, Steven Rowe, Kenneth Pienta, Ajjai Alva, Mark Preston, Frédéric Pouliot, Peter Carroll, Akash Patnaik, Stephan Probst, Bela Denes, Nancy Stambler, Barry Siegel and Michael Morris
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2625;
Lawrence Saperstein
1Yale School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Rowe
2The Russell H Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Pienta
3Johns Hopkins, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ajjai Alva
4University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Preston
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frédéric Pouliot
5CHU de Quebec and Laval University, Quebec City, Quebec
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Carroll
6UCSF, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akash Patnaik
7Department of Medicine, University of Chicago, Chicago, IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan Probst
8Jewish General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bela Denes
9Lantheus Holdings, Inc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy Stambler
9Lantheus Holdings, Inc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barry Siegel
10Washington University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Morris
11Memorial Sloan Kettering Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 63 no. supplement 2 2625

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 8, 2022.

Copyright & Usage 
© 2022

Author Information

  1. Lawrence Saperstein1,
  2. Steven Rowe2,
  3. Kenneth Pienta3,
  4. Ajjai Alva4,
  5. Mark Preston,
  6. Frédéric Pouliot5,
  7. Peter Carroll6,
  8. Akash Patnaik7,
  9. Stephan Probst8,
  10. Bela Denes9,
  11. Nancy Stambler9,
  12. Barry Siegel10 and
  13. Michael Morris11
  1. 1Yale School of Medicine
  2. 2The Russell H Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA
  3. 3Johns Hopkins, Baltimore, MD
  4. 4University of Michigan
  5. 5CHU de Quebec and Laval University, Quebec City, Quebec
  6. 6UCSF, San Francisco, CA
  7. 7Department of Medicine, University of Chicago, Chicago, IL
  8. 8Jewish General Hospital
  9. 9Lantheus Holdings, Inc.
  10. 10Washington University
  11. 11Memorial Sloan Kettering Cancer Center

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2022 to April 2025

AbstractFullPdf
Aug 20222100
Sep 20221900
Oct 20221700
Nov 20221800
Dec 20222300
Jan 20231200
Feb 20231200
Mar 20231000
Apr 2023500
May 20231000
Jun 2023400
Jul 2023500
Aug 2023500
Sep 20231000
Oct 20231200
Nov 20231300
Dec 2023800
Jan 2024800
Feb 20241600
Mar 20242100
Apr 20244300
May 2024700
Jun 20243300
Jul 202410800
Aug 20249200
Sep 20242000
Oct 2024600
Nov 20241700
Dec 2024200
Jan 2025600
Feb 2025400
Mar 2025600
Apr 20251100
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The impact of concomitant use of androgen deprivation therapies (ADT) on the efficacy of piflufolastat F 18-PET/CT in patients with prostate cancer: a sub-group analysis of OSPREY Cohort B
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The impact of concomitant use of androgen deprivation therapies (ADT) on the efficacy of piflufolastat F 18-PET/CT in patients with prostate cancer: a sub-group analysis of OSPREY Cohort B
Lawrence Saperstein, Steven Rowe, Kenneth Pienta, Ajjai Alva, Mark Preston, Frédéric Pouliot, Peter Carroll, Akash Patnaik, Stephan Probst, Bela Denes, Nancy Stambler, Barry Siegel, Michael Morris
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2625;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The impact of concomitant use of androgen deprivation therapies (ADT) on the efficacy of piflufolastat F 18-PET/CT in patients with prostate cancer: a sub-group analysis of OSPREY Cohort B
Lawrence Saperstein, Steven Rowe, Kenneth Pienta, Ajjai Alva, Mark Preston, Frédéric Pouliot, Peter Carroll, Akash Patnaik, Stephan Probst, Bela Denes, Nancy Stambler, Barry Siegel, Michael Morris
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2625;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Regional Pharmacokinetics of [68Ga]Ga-PSMA-11 in Intermediate-to-High-Risk Prostate Cancer Patients Imaged Prior to Prostatectomy
  • Impact of furosemide induced forced diuresis on positivity rate and physiologic radiotracer activity in patients undergoing 68Ga PSMA-11 PET/CT
  • Changes in Quantitative PSMA PET Metrics and PSA Progression-Free Survival following Initiation of Androgen Deprivation Therapy in Prostate Cancer Patients: a retrospective single-center study
Show more GU

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire